Skip to main content

Published

Population pharmacokinetic/pharmacodynamic modelling to evaluate favipiravir in combination with lopinavir-ritonavir in patients with COVID-19.
Agyeman AA. British Journal of Clinical Pharmacology 2026;92(7):2390-2402.
Freely available online

More details
Age Groups
Conditions and Lifestyle Factors
Coronavirus Infections
Settings
Population Health
Staff Groups
Pharmacist